Taxol Approved By FDA For Ovarian Cancer; Bristol Sets Price Tier In Line With Platinum
In Brief: Antman, Chabner Vie For ASCO President-Elect; Irwin Krakoff Is 1993 Karnofsky Lecturer
Frank Rauscher, 62, Former NCI director, Dead Of Heart Attack
HHS: Gallo Committed Scientific Misconduct In AIDS Virus Discovery
IOM To Advise Army On Spending $210 Mil. Breast Cancer Money
Six Panels To Help NCI Identify Progress; NCINews Roundup
Trending Stories
- Richard Pazdur left FDA to avoid being part of “the destruction of the American medical system”
- Pediatric cancer five-year survival rate has increased dramatically, AACR says in inaugural Pediatric Cancer Progress Report
- In first NCAB director’s report, Anthony Letai focuses on centralized grant review, budget outlook
- Antonio Wolff, Mikala Egeblad named co-directors of Johns Hopkins Kimmel Cancer Center Breast and Gynecologic Cancer Program
- Pazdur leaves FDA after 25-year career that shaped the agency’s oncology regulations
BIO calls for the end of “constant turmoil,” urges the administration to “right the ship” - Anthony Letai pledges to ensure stability for extramural and intramural cancer science









